Pharmacokinetics and Monitoring of Cyclosporine Following Orthotopic Liver Transplantation

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Seminars in liver disease (Print)

• Publication date

  1985-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2008-1040633PMID 3909430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects of cyclosporin A: A new antilymphocytic agent

  2005cited by this paper
• Anaphylactoid Reactions Associated with Parenteral Cyclosporine Use: Possible Role of Cremophor EL

  1985cited by this paper
• Biliary Excretion of Cyclosporine in Liver Transplant Patients.

  1985cited by this paper
• Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients.

  1985cited by this paper
• Anaphylactic reaction to intravenous cyclosporine.

  1985cited by this paper
• Cyclosporine

  1985cited by this paper
• Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.

  1985cited by this paper
• Cyclosporine kinetics in renal transplantation

  1985cited by this paper
• The effect of food on cyclosporine absorption.

  1985cited by this paper
• Anaphylactic reaction to intravenous cyclosporin.

  1984cited by this paper
• Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.

  1984cited by this paper
• Simple and rapid high-performance liquid chromatographic analysis of cyclosporine in human blood and serum.

  1984cited by this paper
• High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients.

  1984cited by this paper
• The Clearance of Cyclosporine by Hemodialysis

  1984cited by this paper
• Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.

  1984cited by this paper
• Cyclosporine immunosuppression.

  1983cited by this paper
• Monitoring cyclosporine therapy.

  1983cited by this paper
• Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment.

  1983cited by this paper
• Intravenous cyclosporine kinetics in renal failure

  1983cited by this paper
• Cyclosporin interaction with ketoconazole and melphalan.

  1982cited by this paper
• Liquid-chromatographic determination of cyclosporine in serum with use of a rapid extraction procedure.

  1982cited by this paper
• The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.

  1982cited by this paper
• Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood

  1982cited by this paper
• Liquid-chromatographic determination of cyclosporin A in blood and plasma.

  1981cited by this paper
• A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

  1981cited by this paper
• High-performance liquid chromatographic determination of cyclosporin A in human plasma and urine.

  1980cited by this paper

• A Review of the Pharmacokinetics of Cyclosporin

  2022cites this paper
• Chapter 92 – Special Considerations for Immunosuppression in Children

  2015cites this paper
• Microemulsions for oral administration and their therapeutic applications

  2012cites this paper
• Solid Organ Transplantation

  2011cites this paper
• CHAPTER 2 Changing Perspectives on Liver Transplantation in 1988

  2010cites this paper
• Use of OKT 3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection

  2010cites this paper
• 76 – Special Considerations for Pediatric Immunosuppression After Liver Transplantation

  2005cites this paper
• Wildt ContamInatIon of Breath Methane Samples In SterIlIzed Vacutalner Tubes

  2004cites this paper
• Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.

  2004cites this paper
• Two Specific lmmunoassays of Cyclosporlne Compared In Liver Transplant Recipients

  2004cites this paper
• Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing

  2004cites this paper
• Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants

  2003cites this paper
• Living-related liver transplantation.

  2001cites this paper
• Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe

  2000cites this paper
• Pharmacokinetics of cyclosporin in children with stable renal transplants

  2000influential citation
• TRANSPLANT AT ION / O RIGINAL AR T ICLE

  2000cites this paper
• Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.

  1998cites this paper
• Effect of Oral Adsorbent AST‐120 on Cyclosporin Absorption in Rats

  1997cites this paper
• Biliary strictures in hepatic transplantation: treatment with self-expanding Z stents.

  1996cites this paper
• Current Concepts in Intestinal Peptide Absorption

  1996cites this paper
• Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation

  1996cites this paper
• Liver transplantation with a twenty-four hour delay and an initial low dose of cyclosporine.

  1996cites this paper
• Maintenance Immunosuppressive Drug Therapy and Potential Major Complications

  1996cites this paper
• Effect of the transition from intravenous to oral dosing on cyclosporin-A trough concentrations in liver transplant patients.

  1996cites this paper
• Clinically Significant Drug Interactions with Cyclosporin An Update

  1996cites this paper
• The long-term course of hepatitis C after kidney transplantation.

  1996cites this paper
• Interfaces between medical specialties Renaldysfunction associated withliver transplantation

  1995cites this paper
• A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease

  1995cites this paper
• Renal dysfunction associated with liver transplantation.

  1995cites this paper
• Pharmacokinetics of oral cyclosporine in children awaiting renal transplantation.

  1994cites this paper
• Kidney transplantation in hepatitis B surface antigen carriers

  1994cites this paper
• Pharmacokinetic Evaluation of a New Oral Cyclosporine Formulation

  1994cites this paper
• DIFFERENCES IN ORAL FK506 DOSE REQUIREMENTS BETWEEN ADULT AND PEDIATRIC LIVER TRANSPLANT PATIENTS

  1993cites this paper
• Cimetidine and omeprazole do not affect cyclosporine disposition by the rat liver

  1993cites this paper
• Pharmacokinetics of Cyclosporine A After Intravenous and Oral Administration in Liver Transplant Patients Measured with High‐Performance Liquid Chromatography

  1993cites this paper
• Significance of Cyclosporine Pharmacokinetics in Liver Transplantation

  1993cites this paper
• Measurement of Colonic Tissue Cyclosporine Concentration in Children with Severe Ulcerative Colitis

  1992cites this paper
• The absorption site of cyclosporin in the human gastrointestinal tract.

  1992cites this paper
• Cyclosporine treatment of inflammatory bowel disease.

  1992cites this paper
• Theabsorption site ofcyclosporin inthehumangastro- intestinal tract

  1992cites this paper
• Chapter 38 Postoperative Care Following Hepatic Transplantation

  1992cites this paper
• Cyclosporin pharmacokinetics after intravenous and oral administration in patients with Crohn's disease.

  1992cites this paper
• Postoperative Care Following Hepatic Transplantation

  1992cites this paper
• Enhancement of the oral absorption of cyclosporin in man.

  1992cites this paper
• Isoflurane Alters the Kinetics of Oral Cyclosporine

  1991cites this paper
• Two specific immunoassays of cyclosporine compared in liver transplant recipients.

  1991cites this paper
• Persistent bile leak after liver transplantation: biloma drainage and endoscopic retrograde cholangiopancreatographic sphincterotomy.

  1991cites this paper
• Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation.

  1991cites this paper
• Pharmacology and pharmacokinetics of cyclosporine.

  1991cites this paper
• Management of Drug Interactions With Cyclosporine

  1991cites this paper
• Nursing implications of immunosuppression in transplantation.

  1991cites this paper
• Cyclosporlne Compared In Liver Transplant Recipients

  1991cites this paper
• Practical aspects in the use of cyclosporin in paediatric nephrology

  1991cites this paper
• Factors influencing the pharmacokinetics of cyclosporine in man.

  1991cites this paper
• Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation.

  1990cites this paper
• Liver transplantation: a 31-year perspective. Part II.

  1990cites this paper
• Assay methods for cyclosporine monitoring following liver transplantation

  1990cites this paper
• Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients.

  1990cites this paper
• Pharmacokinetics of cyclosporine: inter- and intra-individual variations and metabolic pathways.

  1990cites this paper
• Comparative Analyses of Cyclosporine in Whole Blood and Plasma by Radioirmmunoassay, Fluorescence Polarization Immunoassay, and High‐Performance Liquid Chromatography

  1990cites this paper
• Therapeutic Drug Monitoring of Cyclosporin

  1989cites this paper
• Continuing management of liver transplant patients after discharge

  1989cites this paper
• Liver transplantation.

  1989cites this paper
• [Liver transplantation in adults: postoperative management and development during the first months].

  1989cites this paper
• Clinical Pharmacokinetics in Organ Transplant Patients

  1989cites this paper
• Postoperative Care After Liver Transplantation

  1989cites this paper
• Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

  1989cites this paper
• Orthotopic liver transplantation: Management of early postoperative complications

  1989cites this paper
• Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction.

  1989cites this paper
• Clinical pharmacokinetics of cyclosporin.

  1989cites this paper
• Pharmacokinetics of cyclosporin A

  1989cites this paper
• Transplantation hépatique chez l'adulte : prise en charge postopératoire et évolution au cours des premiers mois

  1989cites this paper
• Cyclosporine: a review and its specific use in liver transplantation.

  1989cites this paper
• The effect of ischemic liver damage on ciclosporin metabolism

  1989cites this paper
• Effect ofbile oncyclosporin absorption inliver transplant patients

  1988cites this paper
• Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy.

  1988cites this paper
• Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients.

  1988cites this paper
• A Modified Assay for Cyclosporin in Blood Using Solid‐Phase Extraction with High‐Performance Liquid Chromatography

  1988cites this paper
• Modification of the specific Sandimmun kit radioimmunoassay for the measurement of blood cyclosporine by use of a nylon-based second antibody separation.

  1988cites this paper
• Changing perspectives on liver transplantation in 1988.

  1988cites this paper
• Effect of bile on cyclosporin absorption in liver transplant patients.

  1988cites this paper
• Significance of cyclosporine pharmacokinetics.

  1988cites this paper
• CYCLOSPORINE LEVELS IN WHOLE BLOOD: COMPARISON OF THE POLYCLONAL SANDOZ CICLOSPORIN RADIOIMMUNOASSAY KIT WITH THE SPECIFIC ANTIBODY IN THE NEW SANDIMMUN KIT

  1988cites this paper
• Therapeutic drug monitoring of cyclosporine by high-performance liquid chromatography in high volume.

  1988cites this paper
• Liver-function studies in heart-transplant recipients treated with cyclosporin A.

  1988cites this paper
• Comparison of cyclosporine A and G pharmacokinetics.

  1988cites this paper
• Effect of liver dysfunction on cyclosporine pharmacokinetics.

  1987cites this paper
• Intensive care aspects of organ transplantation in children.

  1987cites this paper
• Orthotopic liver transplantation: Postoperative complications and their management

  1987cites this paper
• Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.

  1987cites this paper
• Successful sequential liver‐kidney transplantation in patients with preformed lymphocytotoxic antibodies

  1987cites this paper
• Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring.

  1987cites this paper
• Role of bile and bile salts on cyclosporine absorption in dogs.

  1987cites this paper
• Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

  1987cites this paper
• Use of OKT3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection

  1987cites this paper
• Clinical Pharmacokinetics of Cyclosporin

  1986cites this paper
• Hepatic transplantation.

  1986cites this paper
• Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.

  1986cites this paper
• Southwestern Internal Medicine Conference: Hepatic Transplantation

  1986cites this paper
• Absorption of cyclosporine A after oral dosing.

  1986cites this paper